Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00341900 · ClinicalTrials.gov registry record
Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews
A clinical trial of Frequency of Chromosome Aberrations, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 134
- Enrollment target
- 1
- Study location
NCT00341900: Completed study of Frequency of Chromosome Aberrations, sponsored by National Cancer Institute (NCI).
NCT00341900 is a study of Frequency of Chromosome Aberrations that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 134 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00341900, a study of Frequency of Chromosome Aberrations, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 134 participants
- Enrollment target
- 1
- Study location
Study Summary
Ionizing radiation efficiently induces chromosomal aberrations (CA) and several studies of CA have now been conducted among small groups of flight crews. However, most of the studies only evaluated the unstable aberrations that reflect recent exposures, but not long-term cumulative cosmic radiation exposure. Chromosome painting by fluorescence in situ hybridization (FISH) is a widely used and established cytogenetic method for detecting stable aberrations such as translocations. Thus, FISH can be used for estimating chromosomal damage from cumulative radiation exposure. No large studies of flight crews utilizing FISH have been conducted to date. We propose a study to measure CA using FISH in a group of pilots estimated to have high comic radiation exposure based on flight histories, i.e., those with long duration flying international routes, and a comparison group of university faculty with minimal flying history. These measurements will be used to determine if pilots have elevated frequencies of CA (specifically stable translocations) as compared with the university faculty. In addition, the frequencies of CA will be examined in relation to the cumulative cosmic radiation dose to determine if there is a dose-response relationship. Individual cumulative doses will be calculated from pilot flight histories using a computer program developed by the FAA which estimates cosmic radiation does by accounting for changes in altitude and latitude, and the 11-year solar cycle at the time of the flight. We will collect information on age, lifestyle factors, diet, health history, family cancer history, and medical radiation exposures from personal interview and self-administered dietary questionaire. These factors may affect the CA frequency and so we plan to adjust for them in the statistical analyses. Pilots will be identified based on the Allied Pilots Association roster and faculty from a commercial company that maintains a database of university faculty, including those
Primary Outcome
Chromosome translocation frequency
Conditions Studied
Study Locations (1)
Ohio
- National Institute for Occupational Safety and Health - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2001-11-09 |
| Est. Completion | 2020-04-03 |
What the finished NCT00341900 record still lists
NCT00341900 is an observational study that tracks outcomes without assigning an intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Frequency of Chromosome Aberrations appearing as the primary indexed condition, and to 0 interventions.
NCT00341900 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00341900 about?
NCT00341900 is a clinical study titled "Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews". Ionizing radiation efficiently induces chromosomal aberrations (CA) and several studies of CA have now been conducted among small groups of flight crews. However, most of the studies only evaluated the unstable aberrations that reflect recent exposures, but not long-term cumulative cosmic radiation ...
What is the current status of trial NCT00341900?
This trial is currently completed. The enrollment target is 134 participants. The study started on 2001-11-09. Estimated completion is 2020-04-03.
What conditions does trial NCT00341900 study?
This clinical trial studies the following conditions: Frequency of Chromosome Aberrations.
Who is sponsoring clinical trial NCT00341900?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00341900 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI